Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine

OnabotulinumtoxinA (BT-A) is widely used in medicine for its ability to temporarily paralyze muscles by blocking acetylcholine release, with applications extending beyond cosmetic wrinkle reduction. It is effective in treating various conditions, including neurological disorders like cerebral palsy and multiple sclerosis, urological issues, migraines, excessive sweating, and spasticity. BT-A also targets pain pathways, aiding in the treatment of migraines and neuropathic pain, and shows potential in cancer treatment by affecting cancer cell apoptosis. Additionally, BT-A is being explored for hair loss treatment by enhancing blood flow and reducing inflammation around hair follicles. The therapeutic uses of BT-A continue to expand, with repeated applications enhancing long-term benefits.